APPIA BIO
Appia Bio is a biotechnology company that focuses on the research and development of off-the-shelf allogeneic cell therapies. It works on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
APPIA BIO
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2020-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.appiabio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
52 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
StapleBio
StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
8VC
8VC investment in Series A - Appia Bio
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Series A - Appia Bio
Two Sigma Ventures
Two Sigma Ventures investment in Series A - Appia Bio
Freeflow Ventures
Freeflow Ventures investment in Series A - Appia Bio
WPSS.bio
WPSS.bio investment in Series A - Appia Bio
Bossanova Investimentos
Bossanova Investimentos investment in Series A - Appia Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2023-06-28 | Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs |
Official Site Inspections
http://www.appiabio.com Semrush global rank: 4.73 M Semrush visits lastest month: 1.95 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Appia Bio"
Appia Bio
Pioneering biologists, immuno-engineers, and cell therapy experts comprise Appia Bio's team.See details»
Company — Appia Bio
We’re a biotech company founded in 2020 to discover and develop next-generation allogeneic …See details»
Appia Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Appia Bio is a biotechnology company that focuses on the …See details»
Appia Bio Company Profile 2024: Valuation, Funding
Appia Bio General Information Description. Developer of a stem cell therapy technology intended to discover and develop chimeric antigen receptor-natural …See details»
Appia Bio - LinkedIn
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded …See details»
Appia Bio, Inc. Company Profile | Culver City, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Appia Bio, …See details»
Appia Bio - Overview, News & Similar companies | ZoomInfo.com
Dec 15, 2022 Popular Searches Appia Bio Appia Bio Inc Appiabio SIC Code 87,873 NAICS …See details»
Appia Bio - Research - Overview, Competitors, and Employees
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded …See details»
Appia Bio - Products, Competitors, Financials, Employees, …
About Appia Bio. Appia Bio is a biotechnology company focused on developing engineered …See details»
Appia Bio - VentureRadar
Appia Bio's research and development efforts are focused on creating engineered allogeneic …See details»
Appia Bio - Graduated Companies
Appia Bio is a biotechnology startup dedicated to discovering and developing scalable …See details»
Appia bio launches with $52 million series a financing and …
LOS ANGELES, Calif., May 11, 2021 – Appia Bio, Inc., an early stage biotechnology company …See details»
Appia Bio Launches With $52 Million Series A Financing and …
LOS ANGELES, May 11, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology …See details»
Appia Bio Launches With $52 Million Series A ... - Markets Insider
LOS ANGELES, May 11, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology …See details»
Appia Bio aims for a new kind of off-the-shelf CAR-T with $52M raise
May 11, 2021 Appia Bio launches with $52 million to develop off-the-shelf cell therapies for …See details»
Appia Bio appoints Margo Roberts, Ph.D. to its Board of Directors …
Aug 9, 2022 Dr. Roberts is former CSO of Kite Pharma, Inc. (acquired by Gilead Sciences, …See details»
APPIA BIO NAMES DAMIANO, PHD AS CHIEF SCIENTIFIC OFFICER
LOS ANGELES, Aug. 9, 2022 /PRNewswire/ --Appia Bio, Inc., a preclinical-stage …See details»
Appia Bio names cell therapy manufacturing veteran Qi Wei, PhD …
LOS ANGELES, Calif., May 19, 2021 – Appia Bio, Inc., an early stage biotechnology company …See details»
Technology — Appia Bio
Most allogeneic cells are mature cells from donors. They are engineered, edited, and …See details»
News — Appia Bio
If you're passionate about making waves in cell therapy, we'd love to hear from youSee details»